| Contact |
Contacting PharmaNeuroBoost
For more information on PharmaNeuroBoost and its innovative
product portfolio please contact:
Elly Daniëls, PA
PharmaNeuroBoost NV
Alkerstraat 30 A
3570 Alken, Belgium
Tel.: +32 11 480 750
Fax: +32 11 484 923
E-mail: info@pharmaneuroboost.com
Directions to PharmaNeuroBoost
From Brussels Airport to Alken.
Head northwest on A201 and take exit 3-4 toward E40/E411.
Take the exit onto A3/E40 toward. Take exit onto A2/E314
toward Leuven/Genk/Hasselt. Continue.
Take exit Lummen to merge onto A13/E313 toward Luik/Hasselt.
Take exit 28-Hasselt-Zuid for N80 toward Sint-Truiden/Hasselt.
Keep right at the fork to continue toward
N80/Sint-Truidersteen-weg. Take the second exit of the
roundabout, continue and turn left at the third traffic light.
Continue along the Meerdegatstraat and turn right at the end
(Grootstraat). Take the first left to Alkerstraat. Destination will
be on the right.
For more information on PharmaNeuroBoost and its innovative
product portfolio please contact:
Elly Daniëls, PA
PharmaNeuroBoost NV
Alkerstraat 30 A
3570 Alken, Belgium
Tel.: +32 11 480 750
Fax: +32 11 484 923
E-mail: info@pharmaneuroboost.com
Directions to PharmaNeuroBoost
From Brussels Airport to Alken.
Head northwest on A201 and take exit 3-4 toward E40/E411.
Take the exit onto A3/E40 toward. Take exit onto A2/E314
toward Leuven/Genk/Hasselt. Continue.
Take exit Lummen to merge onto A13/E313 toward Luik/Hasselt.
Take exit 28-Hasselt-Zuid for N80 toward Sint-Truiden/Hasselt.
Keep right at the fork to continue toward
N80/Sint-Truidersteen-weg. Take the second exit of the
roundabout, continue and turn left at the third traffic light.
Continue along the Meerdegatstraat and turn right at the end
(Grootstraat). Take the first left to Alkerstraat. Destination will
be on the right.
| © PharmaNeuroBoost 2011 - All Rights Reserved |
 |  |  |  |  |  |  |  |  |
Click here to view map and get directions |
Publications
| News Highlights |
September 30th, 2011
First Patients Enrolled
in the PNB01 Phase
III clinical develop-
ment program in
Major Depression
August 23rd, 2011
PharmaNeuroBoost
ready to enter Phase
III development with
PNB01 in Major
Depression
First Patients Enrolled
in the PNB01 Phase
III clinical develop-
ment program in
Major Depression
August 23rd, 2011
PharmaNeuroBoost
ready to enter Phase
III development with
PNB01 in Major
Depression